中国药科大学学报
中國藥科大學學報
중국약과대학학보
Journal of China Pharmaceutical University
2015年
5期
548-551
,共4页
闫强%吴书敏%倪礼礼%谢玉锁%高留州%黄文龙%刘英杰%胡国强
閆彊%吳書敏%倪禮禮%謝玉鎖%高留州%黃文龍%劉英傑%鬍國彊
염강%오서민%예례례%사옥쇄%고류주%황문룡%류영걸%호국강
氟喹诺酮%均三唑%噻唑%噻唑并三唑%抗肿瘤活性
氟喹諾酮%均三唑%噻唑%噻唑併三唑%抗腫瘤活性
불규낙동%균삼서%새서%새서병삼서%항종류활성
fluoroquinolone%s-triazole%thiazole%thiazolotriazole%antitumor activity
为寻找抗肿瘤氟喹诺酮类化合物的新方法,用稠杂环核作为培氟沙星(1) C-3羧基的生物电子等排体,设计合成了12个新的噻唑并[3,2-b][1,2,4]三唑类目标化合物(6a~6l),其结构经元素分析和光谱数据确证。选择SMMC-7721、L1210和HL603种肿瘤细胞株进行体外抗增殖活性实验,结果表明目标化合物的抗肿瘤活性高于先导化合物1和相应的开环中间体硫醚酮(5a~5l),其中苯环上有羟基或氟原子取代的目标化合物对SMMC-7721肿瘤细胞显示出较强的活性。基于此,噻唑并均三唑稠杂环可作为氟喹诺酮C-3羧基的等排体用于抗肿瘤氟喹诺酮类化合物的设计。
為尋找抗腫瘤氟喹諾酮類化閤物的新方法,用稠雜環覈作為培氟沙星(1) C-3羧基的生物電子等排體,設計閤成瞭12箇新的噻唑併[3,2-b][1,2,4]三唑類目標化閤物(6a~6l),其結構經元素分析和光譜數據確證。選擇SMMC-7721、L1210和HL603種腫瘤細胞株進行體外抗增殖活性實驗,結果錶明目標化閤物的抗腫瘤活性高于先導化閤物1和相應的開環中間體硫醚酮(5a~5l),其中苯環上有羥基或氟原子取代的目標化閤物對SMMC-7721腫瘤細胞顯示齣較彊的活性。基于此,噻唑併均三唑稠雜環可作為氟喹諾酮C-3羧基的等排體用于抗腫瘤氟喹諾酮類化閤物的設計。
위심조항종류불규낙동류화합물적신방법,용주잡배핵작위배불사성(1) C-3최기적생물전자등배체,설계합성료12개신적새서병[3,2-b][1,2,4]삼서류목표화합물(6a~6l),기결구경원소분석화광보수거학증。선택SMMC-7721、L1210화HL603충종류세포주진행체외항증식활성실험,결과표명목표화합물적항종류활성고우선도화합물1화상응적개배중간체류미동(5a~5l),기중분배상유간기혹불원자취대적목표화합물대SMMC-7721종류세포현시출교강적활성。기우차,새서병균삼서주잡배가작위불규낙동C-3최기적등배체용우항종류불규낙동류화합물적설계。
To search for fluoroquinolones(FQs)with antitumor activity;the C-3 carboxylic acid group of peflox-acin (1)was replaced by fused heterocyclic core;and twelve novel thiazolo[3;2-b][1;2;4]triazole heterocycles(6a-6l)were designed and synthesized.The structures of target compounds were characterized by elemental anal-ysis and spectral data.The results of the in vitro antiproliferative effect on SMMC-7721;L1210 and HL60 cell lines showed that the title compounds exhibited more significant antitumor activity than both of the pefloxacin and the corresponding opening-ring intermediates(5 a-5 l).Among them;the target compounds which possess a ben-zene ring bearing a hydroxyl group (6e)or a fluorine atom (6j)exhibited more potent antiproliferative effect on SMMC-7721 cells than other compounds.Therefore;the antitumor fluoroquinolones can be designed by replacing the C-3 carboxylic acid group of fluoroquinolones with the thiazolo[3;2-b][1;2;4]triazole moiety.